VF
TENX icon

Virtu Financial’s Tenax Therapeutics TENX Stock Holding History

Virtu Financial’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,119
Closed -$92K – 2226
2025
Q3 		$92K Buy
+12,119
New +$74K 0.01% 1056
2023
Q4 		– Sell
-460
Closed -$11K – 1993
2023
Q3 		$11K Buy
+460
New +$11.7K ﹤0.01% 1099
2023
Q2 		– Sell
-1,055
Closed -$39K – 2032
2023
Q1 		$39K Buy
+1,055
New +$110K ﹤0.01% 1141
2022
Q4 		– Sell
-13
Closed -$4K – 2122
2022
Q3 		$4K Buy
+13
New +$5.22K ﹤0.01% 1591
2020
Q4 		– Sell
-13
Closed -$33K – 1786
2020
Q3 		$33K Sell
13
-15
-54% -$32K 0.01% 867
2020
Q2 		$41K Buy
+28
New +$41.2K ﹤0.01% 1032
2019
Q4 		– Sell
-11
Closed -$21K – 1840
2019
Q3 		$21K Buy
+11
New +$22.9K ﹤0.01% 1285
2018
Q2 		– Sell
-8
Closed -$69K – 2490
2018
Q1 		$69K Buy
8
+7
+700% +$80.6K ﹤0.01% 1651
2017
Q4 		$11K Sell
1
-2
-67% -$27.2K ﹤0.01% 2264
2017
Q3 		$37K Buy
+3
New +$44.6K ﹤0.01% 2266

Other funds holding TENX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Virtu Financial's TENX Position: Q4 2025 in Review

Virtu Financial sold out of Tenax Therapeutics (TENX) in Q4 2025, closing a stake of 12,119 shares — an estimated $92K sold.

Virtu Financial first reported a position in TENX in Q3 2017 and held it in 10 quarters. The position peaked at $92K in Q3 2025. 48 funds tracked by Wall St. Rank hold TENX as of Q4 2025.

  • Virtu Financial reported no remaining Tenax Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 12,119 Tenax Therapeutics shares in Q4 2025, an estimated $92K.
  • Virtu Financial first reported a position in Tenax Therapeutics in Q3 2017 and held it in 10 quarters.
  • Virtu Financial's Tenax Therapeutics position peaked at $92K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.